The following article by Phil Kerpen is sponsored by American Commitment.
Last year, the catastrophically misnamed Inflation Reduction Act (IRA) was a punching bag on the campaign trail for raiding about $270 billion from Medicare prescription drug spending to fund green energy and electric vehicle giveaways and other Democratic special interest priorities. Less well-known is that the bill also contained a raid-within-a-raid on small molecule drugs subject to price controls four years earlier than biotech drugs. It’s called the “pill penalty” because it diverts research dollars from pills to injectables.
The IRA arbitrarily sets different standards for “small molecule” drugs, which are those that come in pill, capsule, and tablet form. Pill-form drugs can be subjected to government price controls as soon as nine years after FDA approval, while “large molecule”…
